Review
Copyright ©2014 Baishideng Publishing Group Co.
World J Hematol. Feb 6, 2014; 3(1): 1-17
Published online Feb 6, 2014. doi: 10.5315/wjh.v3.i1.1
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Spectrum of mast cell disease. SM-AHNMD: Systemic mastocytosis with associated clonal hematologic non-mast-cell-lineage disorder.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Diagnostic classification of mastocytosis[33]. SM: Systemic mastocytosis; AHNMD: Associated clonal hematologic non-mast-cell-lineage disorder.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Diagnostic criteria for systemic mastocytosis and mast cell activation syndrome. WHO: World Health Organization; MCs: Mast cells; MCAS: Mast cell activation syndrome; SM: Systemic mastocytosis PG: Prostaglandin.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Validated questionnaire to recognize symptoms as part of a mast cell activation disease in a standardized manner (modified from[39,119]). NSAID: Non-steroidal anti-inflammatory drugs.
Figure 5
Open in New Tab Full Size Figure Download Figure
Figure 5 Diagnostic approach to mast cell activation disease. MCs: Mast cells; MCAS: Mast cell activation syndrome; GI: Gastrointestinal; PG: Prostaglandin; PCR: Polymerase chain reaction; NSAID: Non-steroidal anti-inflammatory drugs.